Page 2 - Kingray Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Kingray capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Kingray Capital Today - Breaking & Trending Today

Epigenic secures funds to advance gene editing therapy

Epigenic Therapeutics has secured $20m in Series Angel and Pre-A funding to proceed with next-generation gene editing therapy. ....

Michael Xue , Bob Zhang , Trinity Innovation Fund , Kingray Capital , Tigeryeah Capital , Morningside Venture Capital , Series Pre A , Fountainbridge Capital , Venture Capital , Epigenic Therapeutics ,

Epigenic Therapeutics Raises $20M in Series Angel and Pre-A Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time! ....

Bob Zhang , Trinity Innovation Fund , Epigenic Therapeutics , Series Angel , Morningside Venture Capital , Kingray Capital , Tigeryeah Capital ,

Epigenic Therapeutics Raises $20 Million in Series Angel and Pre-A Funding to Advance Next Generation Gene Editing Therapy

Press release content from PR Newswire. The AP news staff was not involved in its creation. ....

United States , Hong Kong , Michael Xue , Bob Zhang , Epigenic Therapeutic Technology Platform , Prnewswire Epigenic Therapeutics Co Ltd , Trinity Innovation Fund , Series Angel , Morningside Venture Capital , Kingray Capital , Fountainbridge Capital , Epigenic Therapeutics , Managing Director , Morningside Venture , Epigenic Therapeutic , Chan Family , North America , Innovation Fund , Yeah Capital , Tigeryeah Capital , Venture Capital , Pr Newswire ,

Epigenic Therapeutics Raises $20 Million in Series Angel and Pre-A Funding to Advance Next Generation Gene Editing Therapy - Press Release

SHANGHAI, Aug. 6, 2022 /PRNewswire/ Epigenic Therapeutics Co., Ltd., a frontier biotechnology company dedicated to developing next generation gene ....

United States , Hong Kong , Michael Xue , Bob Zhang , Epigenic Therapeutic Technology Platform , Epigenic Therapeutics Co Ltd , Trinity Innovation Fund , Series Angel , Morningside Venture Capital , Kingray Capital , Fountainbridge Capital , Epigenic Therapeutics , Managing Director , Morningside Venture , Epigenic Therapeutic , Chan Family , North America , Innovation Fund , Yeah Capital , Tigeryeah Capital ,

Epigenic Therapeutics Raises $20 Million in Series Angel and Pre-A Funding to Advance Next Generation Gene Editing Therapy

/PRNewswire/ Epigenic Therapeutics Co., Ltd., a frontier biotechnology company dedicated to developing next generation gene editing therapy utilizing. ....

United States , Hong Kong , Michael Xue , Bob Zhang , Epigenic Therapeutic Technology Platform , Prnewswire Epigenic Therapeutics Co Ltd , Trinity Innovation Fund , Series Angel , Morningside Venture Capital , Kingray Capital , Fountainbridge Capital , Epigenic Therapeutics , Managing Director , Morningside Venture , Epigenic Therapeutic , Chan Family , North America , Innovation Fund , Yeah Capital , Tigeryeah Capital ,